caldecrin

03/01/2011 - "Caldecrin treatment is effective for preventing muscular dystrophy."
03/01/2011 - "Serum calcium-decreasing factor, caldecrin, ameliorates muscular dystrophy in dy/dy mice."

11/26/2015 - "Ectopic intramuscular expression of caldecrin prevented bone resorption in ovariectomized mice. "
05/25/2012 - "Thus, caldecrin is capable of acting as a negative regulator of osteoclastogenesis and osteoclast function of bone resorption."
11/23/2001 - "These results suggest that amino acid sequence corresponding to rat caldecrin (aa 71-79) is responsible for the suppression of bone resorption by caldecrin."
11/26/2015 - "Caldecrin also suppressed the bone resorption activity of mature osteoclasts by preventing RANKL-stimulated Src activation, calcium entry, and actin ring formation. "
07/23/2021 - "The ectopic intramuscular expression of caldecrin cDNA prevents bone resorption in ovariectomized mice, and the administration of caldecrin protein also prevents skeletal muscle destruction in dystrophic mice. "

11/26/2015 - "Caldecrin might be a potential therapeutic target for the treatment of osteolytic diseases such as osteoporosis and osteoarthritis. "

11/26/2015 - "Caldecrin might be a potential therapeutic target for the treatment of osteolytic diseases such as osteoporosis and osteoarthritis. "

03/01/2011 - "Caldecrin gene in hemagglutinating virus of Japan envelop vector (10 μg/head) was single injected in the femoral muscle or daily intraperitoneal administration of caldecrin (100 μg/kg body weight) was given for 4 days in dy/dy mice. "